Melanoma Treatment at a Crossroads: Immune Checkpoints and MAPK-Targeted Therapies
In this GEN webinar, our distinguished guest speaker Dr. Roger Lo will provide insights into his current research on MAP kinase targeted therapies and checkpoint inhibitors for melanoma.